ID   PAPOA_HUMAN             Reviewed;         745 AA.
AC   P51003; Q86SX4; Q86TV0; Q8IYF5; Q9BVU2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Poly(A) polymerase alpha;
DE            Short=PAP-alpha;
DE            EC=2.7.7.19;
DE   AltName: Full=Polynucleotide adenylyltransferase alpha;
GN   Name=PAPOLA; Synonyms=PAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-725 (ISOFORMS 1 AND 2).
RC   TISSUE=B-cell, and Fetal brain;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-660 (ISOFORM 1).
RX   PubMed=8302877; DOI=10.1073/pnas.91.3.979;
RA   Thuresson A.-C., Aastroem J., Aastroem A., Groenvik K.-O.,
RA   Virtanen A.;
RT   "Multiple forms of poly(A) polymerases in human cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:979-983(1994).
RN   [4]
RP   INTERACTION WITH NUDT21/CPSF5.
RX   PubMed=15169763; DOI=10.1074/jbc.M403927200;
RA   Dettwiler S., Aringhieri C., Cardinale S., Keller W., Barabino S.M.;
RT   "Distinct sequence motifs within the 68-kDa subunit of cleavage factor
RT   Im mediate RNA binding, protein-protein interactions, and subcellular
RT   localization.";
RL   J. Biol. Chem. 279:35788-35797(2004).
RN   [5]
RP   IDENTIFICATION IN A COMPLEX WITH CPSF1 AND FIP1L1, AND INTERACTION
RP   WITH FIP1L1.
RX   PubMed=14749727; DOI=10.1038/sj.emboj.7600070;
RA   Kaufmann I., Martin G., Friedlein A., Langen H., Keller W.;
RT   "Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and
RT   stimulates poly(A) polymerase.";
RL   EMBO J. 23:616-626(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   INTERACTION WITH AHCYL1 AND FIP1L1, AND FUNCTION.
RX   PubMed=19224921; DOI=10.1074/jbc.M807136200;
RA   Kiefer H., Mizutani A., Iemura S., Natsume T., Ando H., Kuroda Y.,
RA   Mikoshiba K.;
RT   "Inositol 1,4,5-triphosphate receptor-binding protein released with
RT   inositol 1,4,5-triphosphate (IRBIT) associates with components of the
RT   mRNA 3' processing machinery in a phosphorylation-dependent manner and
RT   inhibits polyadenylation.";
RL   J. Biol. Chem. 284:10694-10705(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-24 AND SER-738,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-558, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Polymerase that creates the 3'-poly(A) tail of mRNA's.
CC       Also required for the endoribonucleolytic cleavage reaction at
CC       some polyadenylation sites. May acquire specificity through
CC       interaction with a cleavage and polyadenylation specificity factor
CC       (CPSF) at its C-terminus. {ECO:0000269|PubMed:19224921}.
CC   -!- CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1).
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 magnesium ions. Also active with manganese.
CC       {ECO:0000250};
CC   -!- SUBUNIT: Monomer. Found in a complex with CPSF1, FIP1L1 and
CC       PAPOLA. Interacts with AHCYL1 and FIP1L1; the interaction with
CC       AHCYL1 seems to increase interaction with FIP1L1
CC       (PubMed:19224921). Interacts with NUDT21; the interaction is
CC       diminished by acetylation. Interacts with KPNB1; the interaction
CC       promotes PAP nuclear import and is inhibited by acetylation of PAP
CC       (By similarity). {ECO:0000250|UniProtKB:P25500,
CC       ECO:0000250|UniProtKB:Q61183, ECO:0000269|PubMed:19224921}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The 90 kDa form is
CC       nuclear while the 100 kDa and the 106 kDa forms are both nuclear
CC       and cytoplasmic.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P51003-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51003-2; Sequence=VSP_012895, VSP_012896;
CC   -!- PTM: Polysumoylated. Varying sumolyation depending on tissue- and
CC       cell-type. Highly sumoylated in bladder and NIH 3T3 cells.
CC       Sumoylation is required for nuclear localization and enhances PAP
CC       stability. Desumoylated by SENP1. Inhibits polymerase activity (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Hyperphosphorylation on multiple CDK2 consensus and non-
CC       consensus sites in the C-terminal Ser/Thr-rich region represses
CC       PAP activity in late M-phase. Phosphorylation/dephosphorylation
CC       may regulate the interaction between PAP and CPSF (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Acetylated in the C-terminus. Acetylation decreases
CC       interaction with NUDT21 and KPNB1, and inhibits nuclear
CC       localization through inhibiting binding to the importin alpha/beta
CC       complex (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the poly(A) polymerase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC000927; AAH00927.1; -; mRNA.
DR   EMBL; BC036014; AAH36014.1; -; mRNA.
DR   EMBL; BX248301; CAD62628.1; -; mRNA.
DR   EMBL; BX248753; CAD66560.1; -; mRNA.
DR   EMBL; BX161482; CAD61935.1; -; mRNA.
DR   EMBL; X76770; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS58334.1; -. [P51003-2]
DR   CCDS; CCDS9946.1; -. [P51003-1]
DR   RefSeq; NP_001238935.1; NM_001252006.1. [P51003-2]
DR   RefSeq; NP_001238936.1; NM_001252007.1.
DR   RefSeq; NP_001280556.1; NM_001293627.1.
DR   RefSeq; NP_001280557.1; NM_001293628.1.
DR   RefSeq; NP_001280561.1; NM_001293632.1.
DR   RefSeq; NP_116021.2; NM_032632.4. [P51003-1]
DR   UniGene; Hs.253726; -.
DR   ProteinModelPortal; P51003; -.
DR   SMR; P51003; -.
DR   BioGrid; 116119; 49.
DR   DIP; DIP-27610N; -.
DR   DIP; DIP-40865N; -.
DR   IntAct; P51003; 10.
DR   MINT; MINT-125699; -.
DR   STRING; 9606.ENSP00000216277; -.
DR   DrugBank; DB02153; 3-Sulfinoalanine.
DR   DrugBank; DB01860; Cordycepin Triphosphate.
DR   DrugBank; DB03896; Triphospate.
DR   iPTMnet; P51003; -.
DR   PhosphoSitePlus; P51003; -.
DR   BioMuta; PAPOLA; -.
DR   DMDM; 59803092; -.
DR   EPD; P51003; -.
DR   MaxQB; P51003; -.
DR   PaxDb; P51003; -.
DR   PeptideAtlas; P51003; -.
DR   PRIDE; P51003; -.
DR   Ensembl; ENST00000216277; ENSP00000216277; ENSG00000090060. [P51003-1]
DR   Ensembl; ENST00000557320; ENSP00000450437; ENSG00000090060. [P51003-2]
DR   GeneID; 10914; -.
DR   KEGG; hsa:10914; -.
DR   UCSC; uc001yfo.5; human. [P51003-1]
DR   CTD; 10914; -.
DR   DisGeNET; 10914; -.
DR   GeneCards; PAPOLA; -.
DR   HGNC; HGNC:14981; PAPOLA.
DR   HPA; HPA001788; -.
DR   MIM; 605553; gene.
DR   neXtProt; NX_P51003; -.
DR   OpenTargets; ENSG00000090060; -.
DR   PharmGKB; PA32932; -.
DR   eggNOG; KOG2245; Eukaryota.
DR   eggNOG; COG5186; LUCA.
DR   GeneTree; ENSGT00390000017928; -.
DR   HOVERGEN; HBG053502; -.
DR   InParanoid; P51003; -.
DR   KO; K14376; -.
DR   OMA; DMKIAAR; -.
DR   OrthoDB; EOG091G0571; -.
DR   PhylomeDB; P51003; -.
DR   TreeFam; TF300842; -.
DR   Reactome; R-HSA-109688; Cleavage of Growing Transcript in the Termination Region.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-77595; Processing of Intronless Pre-mRNAs.
DR   SIGNOR; P51003; -.
DR   ChiTaRS; PAPOLA; human.
DR   GeneWiki; PAPOLA; -.
DR   GenomeRNAi; 10914; -.
DR   PRO; PR:P51003; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000090060; -.
DR   CleanEx; HS_PAPOLA; -.
DR   ExpressionAtlas; P51003; baseline and differential.
DR   Genevisible; P51003; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; ISS:UniProtKB.
DR   GO; GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:Reactome.
DR   GO; GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0031440; P:regulation of mRNA 3'-end processing; IDA:UniProtKB.
DR   GO; GO:0043631; P:RNA polyadenylation; ISS:UniProtKB.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   InterPro; IPR011068; NuclTrfase_I_C.
DR   InterPro; IPR007012; PolA_pol_cen_dom.
DR   InterPro; IPR007010; PolA_pol_RNA-bd_dom.
DR   InterPro; IPR014492; PolyA_polymerase.
DR   InterPro; IPR002934; Polymerase_NTP_transf_dom.
DR   PANTHER; PTHR10682; PTHR10682; 1.
DR   Pfam; PF01909; NTP_transf_2; 1.
DR   Pfam; PF04928; PAP_central; 1.
DR   Pfam; PF04926; PAP_RNA-bind; 1.
DR   PIRSF; PIRSF018425; PolyA_polymerase; 1.
DR   SUPFAM; SSF55003; SSF55003; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Isopeptide bond; Magnesium; Manganese; Metal-binding;
KW   mRNA processing; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding; Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    745       Poly(A) polymerase alpha.
FT                                /FTId=PRO_0000051612.
FT   NP_BIND     100    102       ATP. {ECO:0000250}.
FT   NP_BIND     113    115       ATP. {ECO:0000250}.
FT   NP_BIND     246    247       ATP. {ECO:0000250}.
FT   REGION      508    643       Ser/Thr-rich.
FT   REGION      677    745       Required for interaction with NUDT21.
FT   MOTIF       490    507       Nuclear localization signal 1.
FT                                {ECO:0000250}.
FT   MOTIF       650    665       Nuclear localization signal 2.
FT                                {ECO:0000250}.
FT   COMPBIAS     53     57       Poly-Glu.
FT   COMPBIAS    504    507       Poly-Lys.
FT   METAL       113    113       Magnesium 1; catalytic. {ECO:0000250}.
FT   METAL       113    113       Magnesium 2; catalytic. {ECO:0000250}.
FT   METAL       115    115       Magnesium 1; catalytic. {ECO:0000250}.
FT   METAL       115    115       Magnesium 2; catalytic. {ECO:0000250}.
FT   METAL       167    167       Magnesium 2; catalytic. {ECO:0000250}.
FT   BINDING     109    109       ATP. {ECO:0000250}.
FT   BINDING     167    167       ATP. {ECO:0000250}.
FT   BINDING     228    228       ATP. {ECO:0000250}.
FT   BINDING     237    237       ATP. {ECO:0000250}.
FT   SITE        153    153       Interaction with RNA. {ECO:0000250}.
FT   SITE        158    158       Interaction with RNA. {ECO:0000250}.
FT   SITE        328    328       Interaction with RNA. {ECO:0000250}.
FT   SITE        399    399       Interaction with RNA. {ECO:0000250}.
FT   SITE        524    524       Interaction with RNA. {ECO:0000250}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     537    537       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61183}.
FT   MOD_RES     558    558       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     641    641       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P25500}.
FT   MOD_RES     650    650       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P25500}.
FT   MOD_RES     736    736       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P25500}.
FT   MOD_RES     738    738       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     740    740       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P25500}.
FT   CROSSLNK    444    444       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000305}.
FT   CROSSLNK    445    445       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000305}.
FT   CROSSLNK    506    506       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000305}.
FT   CROSSLNK    507    507       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000305}.
FT   CROSSLNK    736    736       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000250}.
FT   CROSSLNK    740    740       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000250}.
FT   VAR_SEQ     280    285       EWPNPV -> YVFRLY (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_012895.
FT   VAR_SEQ     286    745       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_012896.
FT   CONFLICT      2      3       PF -> GTSNSPGHSSFSAPSTKKIKTTRKQNIAWC (in
FT                                Ref. 2; CAD62628). {ECO:0000305}.
FT   CONFLICT    204    238       CRVTDEILHLVPNIDNFRLTLRAIKLWAKRHNIYS -> MR
FT                                KPTSFCVLQFLSDISCFYTSFVLKLFIAILLTQ (in
FT                                Ref. 2; CAD61935). {ECO:0000305}.
SQ   SEQUENCE   745 AA;  82843 MW;  14A00CCCDAD9B374 CRC64;
     MPFPVTTQGS QQTQPPQKHY GITSPISLAA PKETDCVLTQ KLIETLKPFG VFEEEEELQR
     RILILGKLNN LVKEWIREIS ESKNLPQSVI ENVGGKIFTF GSYRLGVHTK GADIDALCVA
     PRHVDRSDFF TSFYDKLKLQ EEVKDLRAVE EAFVPVIKLC FDGIEIDILF ARLALQTIPE
     DLDLRDDSLL KNLDIRCIRS LNGCRVTDEI LHLVPNIDNF RLTLRAIKLW AKRHNIYSNI
     LGFLGGVSWA MLVARTCQLY PNAIASTLVH KFFLVFSKWE WPNPVLLKQP EECNLNLPVW
     DPRVNPSDRY HLMPIITPAY PQQNSTYNVS VSTRMVMVEE FKQGLAITDE ILLSKAEWSK
     LFEAPNFFQK YKHYIVLLAS APTEKQRLEW VGLVESKIRI LVGSLEKNEF ITLAHVNPQS
     FPAPKENPDK EEFRTMWVIG LVFKKTENSE NLSVDLTYDI QSFTDTVYRQ AINSKMFEVD
     MKIAAMHVKR KQLHQLLPNH VLQKKKKHST EGVKLTALND SSLDLSMDSD NSMSVPSPTS
     ATKTSPLNSS GSSQGRNSPA PAVTAASVTN IQATEVSVPQ VNSSESSGGT SSESIPQTAT
     QPAISPPPKP TVSRVVSSTR LVNPPPRSSG NAATSGNAAT KIPTPIVGVK RTSSPHKEES
     PKKTKTEEDE TSEDANCLAL SGHDKTEAKE QLDTETSTTQ SETIQTAASL LASQKTSSTD
     LSDIPALPAN PIPVIKNSIK LRLNR
//
